行情

PRPH

PRPH

Prophase Lab
NASDAQ

实时行情|Nasdaq Last Sale

1.990
-0.090
-4.32%
已收盘, 16:00 12/09 EST
开盘
1.993
昨收
2.080
最高
2.023
最低
1.990
成交量
3,273
成交额
--
52周最高
3.284
52周最低
1.443
市值
2,301.55万
市盈率(TTM)
-7.3354
分时
5日
1月
3月
1年
5年

PRPH 新闻

  • 报告:6家硅谷巨头过去10年全球避税1000亿美元
  • 新浪科技.6天前
  • 报告:秘鲁2019年三季度倒闭公司数量同比增五成
  • 中国新闻网.6天前
  • 英国保守党支持率较工党的领先优势扩大至12个百分点
  • 新浪财经综合.6天前
  • 拼多多无证经营支付踩雷区 上海央行正督促其整改
  • 21世纪经济报道.6天前

更多

所属板块

食品加工
+0.11%
食品和烟类
+0.25%

热门股票

名称
价格
涨跌幅

PRPH 简况

ProPhase Labs, Inc. manufactures, markets and distributes a range of homeopathic and healthcare products. The Company is engaged in the research and development of over-the-counter (OTC) drugs and natural base health products, including supplements, personal care and cosmeceutical products. The Company's products include TK Supplements and ORXx Complete. TK Supplements consists of LEGENDZ XL, a male sexual enhancement; TRIPLE EDGE XL, a daily energy and stamina booster, and SUPER PROSTAFLOW plus, a supplement to support prostate and urinary health. The Company's OTC offerings include the ORXx cough/cold drops. Its consumer health customers include national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies.
展开

Webull提供ProPhase Labs Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。